By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators publish new report on Opioids. Financial supporters for this research include NIH National Institute on Drug Abuse, Office ...

Mistreatment means LGBTQ+ people are less likely to contact the police, affecting the statistics on crime against them.

The Nexus of Open Science symposium took place on Nov. 14, bringing together leaders in neuroscience, clinical research, ...

Background Cervical cancer is one of the leading causes of death among women in Africa, but stigma often delays cervical ...

Objectives To alleviate the shortage of qualified physicians in rural areas, since 2010, the Chinese government has launched a National Compulsory Service Programme (NCSP) to enrol medical students ...

BraDiPho is an innovative tool for the study of white matter connections in the human brain. A realistic map developed by a ...

Introduction Saskatchewan is facing a public health crisis driven by high rates of HIV, syphilis and hepatitis C virus (HCV) infections, particularly among people who use drugs. Injection drug use is ...

Inhibrx Biosciences shares jumped in premarket trading after the company reported positive trial results for its cancer drug ozekibart, including promising data from expanded use. Shares jumped 62% to ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from GH Research ( (GHRS) ...

Posters will be available to view on the conference platform during the conference and on the Company’s website here after presentations. Further information about IDWeek™ 2025 can be found here.

Healthcare professionals gather to promote new telemedicine services aimed at closing gaps in men’s mental and sexual health access. Fewer than one in three Kenyan men seek regular medical care, a ...

The MarketWatch News Department was not involved in the creation of this content. Vyome's offering is a first-of-its-kind in a broader $20B potential addressable ocular inflammation market VT-1908 ...